Bliss Aesthetics operates an AI-driven platform that uses GenAI, Stable Diffusion, and computer vision models to let patients realistically visualize cosmetic enhancements and match with board-certified physicians. The product combines an AI-powered decision engine, intelligent matchmaking, and 24/7 customer assistance while surfacing potential financing partners. Bliss reports improving patient engagement from 40% to 80% and a 500% growth in its provider base since launch. The platform is available to patients across Florida, Texas, Illinois, Arizona, Michigan, and North Carolina. Leadership includes Co-Founder and CEO Gal Yosef and co-founder/Chief Medical Officer Dr. Michael Salzhauer. The company says it will use the new capital to grow the platform and expand into additional states as the cosmetic procedure market scales.

Total raised

$18M

Funding rounds

1

Latest round

Seed

Latest activity

Apr 2025